Illumina, Inc. (NASDAQ: ILMN), Dendreon Co. (NASDAQ: DNDN), Clearwire (NASDAQ: CLWR), Cinemark Holdings Inc. (NYSE: CNK), Kraton Performance Polymers Inc. (NYSE: KRA) and US Airways Group, Inc. (NYSE: LCC) ratings and price targets.
Illumina, Inc. (ILMN) is now covered by Cantor Fitzgerald. They have a “Hold” rating on the company.
Dendreon Co. (DNDN) had its “Overweight” rating reiterated by JPMorgan Chase & Co. (NYSE:JPM).
Clearwire (CLWR) had its “Neutral” rating reiterated by UBS AG (NYSE:UBS).
Cinemark Holdings Inc. (CNK) had its “Neutral” rating reiterated by Wedbush.
Kraton Performance Polymers Inc. (KRA) had its “Buy” rating reiterated by UBS AG.
US Airways Group, Inc. (LCC) had its “Hold” rating reiterated by Dahlman Rose.
Showing posts with label Illumina. Show all posts
Showing posts with label Illumina. Show all posts
Friday, January 6, 2012
Monday, August 8, 2011
Seabright (SBX) (ILMN) (LNKD) (SMRT) (TTGT) Downgraded
Seabright Holdings, Inc. (NYSE: SBX), Illumina, Inc. (NASDAQ: ILMN), Linkedin Co. (NASDAQ: LNKD), Stein Mart (NASDAQ: SMRT) and TechTarget Inc (NASDAQ: TTGT) downgraded by analysts.
Seabright Holdings, Inc. (SBX) was downgraded by JMP Securities from a “Market Perform” rating to an “Underperform” rating.
Illumina, Inc. (ILMN) was downgraded by Goldman Sachs (NYSE:GS) from a “Buy” rating to a “Neutral” rating.
Linkedin Co. (LNKD) was downgraded by Evercore Partners from an “Equal Weight” rating to an “Underweight” rating. They cited valuation as the catalyst behind their call.
Stein Mart (SMRT) was downgraded by SunTrust (NYSE:STI) from a “Buy” rating to a “Neutral” rating.
TechTarget Inc. (TTGT) was downgraded by Lazard Capital from a “Buy” rating to a “Neutral” rating.
Seabright Holdings, Inc. (SBX) was downgraded by JMP Securities from a “Market Perform” rating to an “Underperform” rating.
Illumina, Inc. (ILMN) was downgraded by Goldman Sachs (NYSE:GS) from a “Buy” rating to a “Neutral” rating.
Linkedin Co. (LNKD) was downgraded by Evercore Partners from an “Equal Weight” rating to an “Underweight” rating. They cited valuation as the catalyst behind their call.
Stein Mart (SMRT) was downgraded by SunTrust (NYSE:STI) from a “Buy” rating to a “Neutral” rating.
TechTarget Inc. (TTGT) was downgraded by Lazard Capital from a “Buy” rating to a “Neutral” rating.
Monday, August 1, 2011
CryoLife (CRY) (EVEP) (HIW) (ILMN) (VRTX) (WLL) Upgraded
CryoLife, Inc. (NYSE: CRY), EV Energy (NASDAQ: EVEP), Highwoods (NYSE: HIW), Illumina, Inc. (NASDAQ: ILMN), Vertex Pharmaceuticals (NASDAQ: VRTX) and Whiting Petroleum Co. (NYSE: WLL) upgraded by analysts.
CryoLife, Inc. (CRY) was upgraded by The Benchmark Company from a “Hold” rating to a “Buy” rating. They have a price target of $6.50 on the company.
EV Energy (EVEP) was upgraded by analysts at Wells Fargo & Co. (NYSE:WFC) from a “Market Perform” rating to an “Outperform” rating.
Highwoods (HIW) was upgraded by Stifel Nicolaus from a “Hold” rating to a “Buy” rating. They have a price target of $38.00 on the company.
Illumina, Inc. (ILMN) was upgraded by Mizuho from a “Neutral” rating to an “Outperform” rating.
Vertex Pharmaceuticals (VRTX) was upgraded by Citigroup (NYSE:C) from a “Hold” rating to a “Buy” rating. They have a price target of $60.00 on the company.
Whiting Petroleum Co. (WLL) was upgraded by Ticonderoga from a “Neutral” rating to a “Buy” rating. They have a price target of $65.00 on the company.
CryoLife, Inc. (CRY) was upgraded by The Benchmark Company from a “Hold” rating to a “Buy” rating. They have a price target of $6.50 on the company.
EV Energy (EVEP) was upgraded by analysts at Wells Fargo & Co. (NYSE:WFC) from a “Market Perform” rating to an “Outperform” rating.
Highwoods (HIW) was upgraded by Stifel Nicolaus from a “Hold” rating to a “Buy” rating. They have a price target of $38.00 on the company.
Illumina, Inc. (ILMN) was upgraded by Mizuho from a “Neutral” rating to an “Outperform” rating.
Vertex Pharmaceuticals (VRTX) was upgraded by Citigroup (NYSE:C) from a “Hold” rating to a “Buy” rating. They have a price target of $60.00 on the company.
Whiting Petroleum Co. (WLL) was upgraded by Ticonderoga from a “Neutral” rating to a “Buy” rating. They have a price target of $65.00 on the company.
Monday, May 9, 2011
Big Movers (ILMN) (PPO) (ALJ) (HUM) (AREX) on May 6
Among the big, positive movers on Friday, May 6, were Illumina (ILMN), Polypore International (PPO), Alon USA Energy (ALJ), Humana Inc. (HUM) and Approach Resources (AREX).
Illumina (ILMN) jumped $1.75, to close at $71.18, a gain of 2.52 percent.
Polypore International (PPO) was up $1.74 on the day to close at $67.62, a gain of 2.64 percent.
Alon USA Energy (ALJ) climbed $1.74 to close at $13.21, a gain of 15.17 percent.
Humana Inc. (HUM) rose $1.71 to close the session at $76.95, a gain of 6.40 2.27.
Approach Resources (AREX) was up $1.71 to end the day at $24.71, a gain of 7.43 percent.
Illumina (ILMN) jumped $1.75, to close at $71.18, a gain of 2.52 percent.
Polypore International (PPO) was up $1.74 on the day to close at $67.62, a gain of 2.64 percent.
Alon USA Energy (ALJ) climbed $1.74 to close at $13.21, a gain of 15.17 percent.
Humana Inc. (HUM) rose $1.71 to close the session at $76.95, a gain of 6.40 2.27.
Approach Resources (AREX) was up $1.71 to end the day at $24.71, a gain of 7.43 percent.
Thursday, April 28, 2011
Illumina (ILMN) (GPK) (SNN) (REGN) Get Coverage Initiations from Analysts
Illumina, Inc. (NASDAQ: ILMN), Graphic Packaging Holding Company (NYSE: GPK), Smith & Nephew plc (NYSE: SNN) and Regeneron Pharms (NASDAQ: REGN) now getting coverage initiated by these analysts.
Goldman Sachs (NYSE:GS) initiated coverage on Graphic Packaging Holding Company (GPK). They started them with a “Buy” rating and a price target of $6.25 a share.
Bank of America (NYSE:BAC) initiated coverage on Smith & Nephew plc (SNN). They started them with a “Neutral” rating.
Auriga initiated coverage on Illumina, Inc. (ILMN). They started them off with a “Buy” rating and a price target of $75.
Boenning & Scattergood initiated coverage on Regeneron Pharms (REGN). They started them with an “Outperform” rating and a price target of $58.
Goldman Sachs (NYSE:GS) initiated coverage on Graphic Packaging Holding Company (GPK). They started them with a “Buy” rating and a price target of $6.25 a share.
Bank of America (NYSE:BAC) initiated coverage on Smith & Nephew plc (SNN). They started them with a “Neutral” rating.
Auriga initiated coverage on Illumina, Inc. (ILMN). They started them off with a “Buy” rating and a price target of $75.
Boenning & Scattergood initiated coverage on Regeneron Pharms (REGN). They started them with an “Outperform” rating and a price target of $58.
Thursday, January 13, 2011
Illumina (NASDAQ:ILMN) Unveils New Sequencing Instrument, MiSeq
Goldman Sachs (NYSE:GS) says they're maintaining their rating on Illumina (NASDAQ:ILMN) after the unveiled a new sequencing instrument, MiSeq.
Also noted was the growing backlog of Illumina for its sequencing services, along with lower cost arrays.
Goldman raised their full year EPS estimates for 2011 through 2013 from 1.52, $1.92, and $2.31 to $1.48, $2.00, and $2.58.
They maintains their "Buy" rating on Illumina, which closed Wednesday at $66.95, down $0.39, or 0.58 percent. Goldman raised their price target on Illumina from $74 to $81.
Also noted was the growing backlog of Illumina for its sequencing services, along with lower cost arrays.
Goldman raised their full year EPS estimates for 2011 through 2013 from 1.52, $1.92, and $2.31 to $1.48, $2.00, and $2.58.
They maintains their "Buy" rating on Illumina, which closed Wednesday at $66.95, down $0.39, or 0.58 percent. Goldman raised their price target on Illumina from $74 to $81.
Tuesday, December 14, 2010
Illumina's (NASDAQ:ILMN) Genetic Analysis Tools Remain Strong
Illumina (NASDAQ:ILMN) continues to be a bullish choice of UBS (NYSE:UBS), which sees no problems with support, assuming no major disruptions come to the customer R&D funding.
UBS also sees them continuing to be led by their genetic analysis tools.
"While the stock has more than doubled this year and commands a hefty premium, our review of the competitive landscape suggests that ILMN’s position is firm. Furthermore, baring any major disruptions to customer R&D funding, demand for the company’s leading edge genetic analysis tools should remain strong...For 2010-12, we now project revenues of $894M (+34%), $1,087M (+22%), & $1,295M (+18%) and EPS of $1.06, $1.40, & $1.89, respectively, vs. our prior forecasts of $888M, $1,080M, & $1,291M and EPS of $1.04, $1.38, & $1.73," said UBS.
UBS Maintains a "Buy" on Illumina, which closed at $64.71 Monday. They have a price target of $72 on them, raising it from $60.
UBS also sees them continuing to be led by their genetic analysis tools.
"While the stock has more than doubled this year and commands a hefty premium, our review of the competitive landscape suggests that ILMN’s position is firm. Furthermore, baring any major disruptions to customer R&D funding, demand for the company’s leading edge genetic analysis tools should remain strong...For 2010-12, we now project revenues of $894M (+34%), $1,087M (+22%), & $1,295M (+18%) and EPS of $1.06, $1.40, & $1.89, respectively, vs. our prior forecasts of $888M, $1,080M, & $1,291M and EPS of $1.04, $1.38, & $1.73," said UBS.
UBS Maintains a "Buy" on Illumina, which closed at $64.71 Monday. They have a price target of $72 on them, raising it from $60.
Subscribe to:
Posts (Atom)